CLBS logo

Caladrius Biosciences (CLBS) Current Liabilities

Annual Current Liabilities

$4.52 M
+$1.02 M+29.01%

December 31, 2021

Summary

Performance

1-Year Change

+29.01%

3-Year Change

-19.51%

5-Year Change

-51.44%

15-Year Change

-51.44%

CLBS Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$36.45 M
CLBS annual total current liabilities is currently -87.59% below its historical high of $36.45 million

3-Year Low

$4.52 M
CLBS annual total current liabilities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
CLBS previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
CLBS next annual earnings announcement has not yet been scheduled

OtherCLBSbalance sheetmetrics:

Annual Total Liabilities

$5.01 M
CLBS annual total liabilities is $5.01 million

Annual Total Long Term Liabilities

$485.00 K
CLBS annual total long term liabilities is $485.00 thousand

Annual Total Assets

$97.01 M
CLBS annual total assets is $97.01 million

Annual Current Assets

$96.18 M
CLBS annual total current assets is $96.18 million

Quarterly Current Liabilities

$6.39 M
+$3.03 M+90.38%

September 1, 2022

Summary

Performance

3-Month Change

+90.38%

1-Year Change

+56.95%

3-Year Change

+6.89%

5-Year Change

-43.81%

CLBS Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$50.44 M
CLBS quarterly total current liabilities is currently -87.33% below its historical high of $50.44 million

3-Year Low

$2.80 M
CLBS quarterly total current liabilities is currently +128.17% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2022
CLBS previous earnings announcement was published on Sep 1, 2022

Next Quarterly Earnings Report Date

N/A
CLBS next earnings announcement has not yet been scheduled

OtherCLBSbalance sheetmetrics:

Quarterly Total Liabilities

$6.76 M
CLBS quarterly total liabilities is $6.76 million

Quarterly Long Term Liabilities

$367.00 K
CLBS quarterly total long term liabilities is $367.00 thousand

Quarterly Total Assets

$78.53 M
CLBS quarterly total assets is $78.53 million

Quarterly Current Assets

$77.29 M
CLBS quarterly total current assets is $77.29 million

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

Annual Current Liabilities

$4.52 M
CLBS annual total current liabilities is $4.52 million

Annual Accounts Payable

$1.93 M
CLBS annual accounts payable is $1.93 million

Annual Short Term Debt

$229.00 K
CLBS annual short term debt is $229.00 thousand

CLBS Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+29.0%+57.0%
3 y3 years-19.5%+6.9%
5 y5 years-51.4%-43.8%

CLBS Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat lowat high-56.2%
5 y5-year-24.3%-22.5%at high-56.2%
alltimeall time-87.6%-94.3%-87.3%-95.4%

Caladrius Biosciences Current Liabilities History

DateAnnualQuarterly
Sep 2022
-
$6.39 M(+90.4%)
Jun 2022
-
$3.36 M(+19.9%)
Mar 2022
-
$2.80 M(-38.1%)
Dec 2021
$4.52 M(+29.0%)
$4.52 M(+11.1%)
Sep 2021
-
$4.07 M(+5.6%)
Jun 2021
-
$3.86 M(-13.1%)
Mar 2021
-
$4.44 M(+26.6%)
Dec 2020
$3.51 M(-41.3%)
$3.51 M(-16.1%)
Sep 2020
-
$4.18 M(+20.1%)
Jun 2020
-
$3.48 M(-24.7%)
Mar 2020
-
$4.62 M(-22.7%)
Dec 2019
$5.98 M(+6.4%)
$5.98 M(-0.1%)
Sep 2019
-
$5.98 M(+4.7%)
Jun 2019
-
$5.71 M(+12.0%)
Mar 2019
-
$5.10 M(-9.2%)
Dec 2018
$5.62 M(-39.7%)
$5.62 M(+14.9%)
Sep 2018
-
$4.89 M(-16.1%)
Jun 2018
-
$5.83 M(-26.8%)
Mar 2018
-
$7.96 M(-14.6%)
Dec 2017
$9.31 M(-56.0%)
$9.31 M(-18.1%)
Sep 2017
-
$11.37 M(-21.8%)
Jun 2017
-
$14.55 M(-37.3%)
Mar 2017
-
$23.21 M(+9.6%)
Dec 2016
$21.18 M(+0.8%)
$21.18 M(+14.2%)
Sep 2016
-
$18.55 M(-17.0%)
Jun 2016
-
$22.36 M(+21.1%)
Mar 2016
-
$18.46 M(-12.1%)
Dec 2015
$21.02 M(+29.4%)
$21.02 M(+6.5%)
Sep 2015
-
$19.74 M(+20.9%)
Jun 2015
-
$16.33 M(-6.5%)
Mar 2015
-
$17.46 M(+7.5%)
Dec 2014
$16.24 M(+65.6%)
$16.24 M(+37.0%)
Sep 2014
-
$11.85 M(-0.5%)
Jun 2014
-
$11.91 M(+35.6%)
Mar 2014
-
$8.79 M(-10.4%)
Dec 2013
$9.81 M(-1.4%)
$9.81 M(-2.3%)
Sep 2013
-
$10.04 M(+19.7%)
Jun 2013
-
$8.38 M(-9.1%)
Mar 2013
-
$9.23 M(-7.2%)
Dec 2012
$9.95 M(-72.7%)
$9.95 M(-80.3%)
Sep 2012
-
$50.44 M(+5.0%)
Jun 2012
-
$48.02 M(+1.9%)
Mar 2012
-
$47.14 M(+29.3%)
Dec 2011
$36.45 M(+11.0%)
$36.45 M(+15.6%)
Sep 2011
-
$31.52 M(-18.7%)
Jun 2011
-
$38.77 M(-5.3%)
Mar 2011
-
$40.95 M(+24.7%)
Dec 2010
$32.84 M
$32.84 M(+59.7%)
DateAnnualQuarterly
Sep 2010
-
$20.57 M(-22.9%)
Jun 2010
-
$26.68 M(-14.4%)
Mar 2010
-
$31.17 M(+23.6%)
Dec 2009
$25.22 M(+2524.5%)
$25.22 M(+841.3%)
Sep 2009
-
$2.68 M(+183.9%)
Jun 2009
-
$944.00 K(-63.9%)
Mar 2009
-
$2.62 M(+172.1%)
Dec 2008
$961.10 K(+116.4%)
$961.10 K(+109.8%)
Sep 2008
-
$458.10 K(+55.1%)
Jun 2008
-
$295.40 K(-25.0%)
Mar 2008
-
$393.80 K(-11.3%)
Dec 2007
$444.20 K(-47.0%)
$444.20 K(+24.3%)
Sep 2007
-
$357.40 K(-54.5%)
Jun 2007
-
$785.90 K(+51.0%)
Mar 2007
-
$520.40 K(-37.9%)
Dec 2006
$838.30 K(-52.2%)
$838.30 K(+52.8%)
Sep 2006
-
$548.80 K(-79.4%)
Jun 2006
-
$2.66 M(+57.5%)
Mar 2006
-
$1.69 M(-3.5%)
Dec 2005
$1.75 M(+36.1%)
$1.75 M(-6.4%)
Sep 2005
-
$1.87 M(+15.0%)
Jun 2005
-
$1.63 M(+15.5%)
Mar 2005
-
$1.41 M(+9.4%)
Dec 2004
$1.29 M(+25.9%)
$1.29 M(-10.5%)
Sep 2004
-
$1.44 M(+17.9%)
Jun 2004
-
$1.22 M(+1.8%)
Mar 2004
-
$1.20 M(+17.2%)
Dec 2003
$1.02 M(-10.4%)
$1.02 M(+0.4%)
Sep 2003
-
$1.02 M(-34.4%)
Jun 2003
-
$1.55 M(+19.9%)
Mar 2003
-
$1.30 M(+13.5%)
Dec 2002
$1.14 M(+133.1%)
$1.14 M(+8.8%)
Sep 2002
-
$1.05 M(+37.9%)
Jun 2002
-
$760.80 K(+30.7%)
Mar 2002
-
$582.20 K(+18.9%)
Dec 2001
$489.50 K(+6.8%)
$489.50 K(+7.4%)
Sep 2001
-
$455.80 K(+5.3%)
Jun 2001
-
$432.90 K(+2.9%)
Mar 2001
-
$420.80 K(-8.2%)
Dec 2000
$458.40 K(-47.5%)
$458.40 K(-9.0%)
Sep 2000
-
$503.50 K(+0.8%)
Jun 2000
-
$499.30 K(+19.1%)
Mar 2000
-
$419.30 K
Dec 1999
$872.90 K(+132.4%)
-
Dec 1998
$375.60 K(+44.6%)
-
Mar 1998
$259.70 K(-61.0%)
-
Mar 1997
$666.60 K(+46.4%)
-
Mar 1996
$455.30 K
-

FAQ

  • What is Caladrius Biosciences annual total current liabilities?
  • What is the all time high annual current liabilities for Caladrius Biosciences?
  • What is Caladrius Biosciences annual current liabilities year-on-year change?
  • What is Caladrius Biosciences quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Caladrius Biosciences?
  • What is Caladrius Biosciences quarterly current liabilities year-on-year change?

What is Caladrius Biosciences annual total current liabilities?

The current annual current liabilities of CLBS is $4.52 M

What is the all time high annual current liabilities for Caladrius Biosciences?

Caladrius Biosciences all-time high annual total current liabilities is $36.45 M

What is Caladrius Biosciences annual current liabilities year-on-year change?

Over the past year, CLBS annual total current liabilities has changed by +$1.02 M (+29.01%)

What is Caladrius Biosciences quarterly total current liabilities?

The current quarterly current liabilities of CLBS is $6.39 M

What is the all time high quarterly current liabilities for Caladrius Biosciences?

Caladrius Biosciences all-time high quarterly total current liabilities is $50.44 M

What is Caladrius Biosciences quarterly current liabilities year-on-year change?

Over the past year, CLBS quarterly total current liabilities has changed by +$2.32 M (+56.95%)